[Federal Register Volume 73, Number 19 (Tuesday, January 29, 2008)]
[Notices]
[Pages 5211-5212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-1508]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-1110 (Final)]


Notice of Commission Determination to Conduct a Portion of the 
Hearing In Camera

AGENCY: U.S. International Trade Commission.

ACTION: Closure of a portion of a Commission hearing.

-----------------------------------------------------------------------

SUMMARY: Upon request of Chinese producer, Hubei Xingfa Chemical Group 
Company, Ltd. (Xingfa), the Commission has determined to conduct a 
portion of its hearing in the above-captioned investigation scheduled 
for January 24, 2008, in camera. See Commission rules 207.24(d), 
201.13(m) and 201.36(b)(4) (19 CFR 207.24(d), 201.13(m) and 
201.36(b)(4)). The remainder of the hearing will be open to the public. 
The Commission has determined that the seven-day advance notice of the 
change to a meeting was not possible. See Commission rule 201.35(a), 
(c)(1) (19 CFR 201.35(a), (c)(1)).

FOR FURTHER INFORMATION CONTACT: Robin L. Turner, Esq., Office of the 
General Counsel, United States International Trade Commission, 202-205-
3103. Hearing-impaired individuals are advised that information on this 
matter may be obtained by contacting the Commission's TDD terminal on 
202-205-3105.

SUPPLEMENTARY INFORMATION: The Commission believes that Xingfa has 
justified the need for a closed session. In this review, significant 
data for the domestic and foreign producers and subject imports are 
business proprietary. Xingfa seeks a closed session in order to fully 
address the issues before the Commission without referring to business 
proprietary information. In making this decision, the Commission 
nevertheless reaffirms its belief that

[[Page 5212]]

whenever possible its business should be conducted in public.
    The hearing will include the usual public presentations by 
petitioners and by respondents, with questions from the Commission. In 
addition, the hearing will include a 10-minute in camera session for a 
confidential presentation by Chinese Respondent, Xingfa. This session 
will be followed by questions from the Commission relating to the BPI 
and a 10-minute in camera rebuttal presentation by petitioners, if 
needed. Following the in camera session, the Commission will reopen the 
hearing to the public for the public rebuttal/closing statements. 
During the in camera session the room will be cleared of all persons 
except those who have been granted access to BPI under a Commission 
administrative protective order (APO) and are included on the 
Commission's APO service list in this investigation. See 19 CFR 
201.35(b). The time for the parties' presentations and rebuttals in the 
in camera session will be taken from their respective overall time 
allotments for the hearing. All persons planning to attend the in 
camera portions of the hearing should be prepared to present proper 
identification.

    Authority: The General Counsel has certified, pursuant to 
Commission Rule 201.39 (19 CFR 201.39) that a portion of the 
Commission's hearing in Sodium Hexametaphosphate from China, Inv. 
No. 731-TA-1110 (Final), may be closed to the public to prevent the 
disclosure of BPI.

    Issued: January 22, 2008.

    By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
 [FR Doc. E8-1508 Filed 1-28-08; 8:45 am]
BILLING CODE 7020-02-P